George Plitas

9.2k total citations · 3 hit papers
73 papers, 5.3k citations indexed

About

George Plitas is a scholar working on Oncology, Cancer Research and Immunology. According to data from OpenAlex, George Plitas has authored 73 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 31 papers in Cancer Research and 30 papers in Immunology. Recurrent topics in George Plitas's work include Breast Cancer Treatment Studies (25 papers), Immune Cell Function and Interaction (18 papers) and T-cell and B-cell Immunology (17 papers). George Plitas is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), Immune Cell Function and Interaction (18 papers) and T-cell and B-cell Immunology (17 papers). George Plitas collaborates with scholars based in United States, Spain and Russia. George Plitas's co-authors include Alexander Y. Rudensky, Ronald P. DeMatteo, Eric G. Pamer, Katharina Brandl, Zubin M. Bamboat, Bernd Schnabl, Paula D. Bos, Monica Morrow, Dana Pe’er and Vaidotas Kiseliovas and has published in prestigious journals such as Nature, Cell and Journal of Clinical Investigation.

In The Last Decade

George Plitas

67 papers receiving 5.2k citations

Hit Papers

Single-Cell Map of Diverse Immune Phe... 2008 2026 2014 2020 2018 2008 2016 400 800 1.2k

Peers

George Plitas
Florencia McAllister United States
Youhai Chen United States
Robert M. Hershberg United States
Sergei B. Koralov United States
Anne Müller Switzerland
Florencia McAllister United States
George Plitas
Citations per year, relative to George Plitas George Plitas (= 1×) peers Florencia McAllister

Countries citing papers authored by George Plitas

Since Specialization
Citations

This map shows the geographic impact of George Plitas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Plitas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Plitas more than expected).

Fields of papers citing papers by George Plitas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Plitas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Plitas. The network helps show where George Plitas may publish in the future.

Co-authorship network of co-authors of George Plitas

This figure shows the co-authorship network connecting the top 25 collaborators of George Plitas. A scholar is included among the top collaborators of George Plitas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Plitas. George Plitas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Abuhadra, Nour, Fresia Pareja, Hannah Y. Wen, et al.. (2025). Predictors of response to neoadjuvant chemo-immunotherapy in metaplastic triple-negative breast cancer. npj Breast Cancer. 11(1). 110–110.
3.
Ferraro, Emanuela, Atif J. Khan, George Plitas, et al.. (2024). Abstract PO3-04-07: Characterization of response to first-line chemotherapy, trastuzumab, and pertuzumab among patients with de novo metastatic HER2-positive breast cancer. Cancer Research. 84(9_Supplement). PO3–4. 1 indexed citations
4.
Cabel, Luc, David M. Kurtz, Daniel W. Ross, et al.. (2024). 293P Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq. Annals of Oncology. 35. S338–S338. 1 indexed citations
5.
Comen, Elizabeth, Sadna Budhu, Yuval Elhanati, et al.. (2024). Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer. iScience. 27(2). 108880–108880. 5 indexed citations
6.
Myers, Sara P., Nour Abuhadra, Giacomo Montagna, et al.. (2023). Impact of neoadjuvant chemo-immunotherapy on surgical outcomes and time to radiation in triple negative breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 555–555.
7.
Beck, Anna C., George Plitas, Varadan Sevilimedu, et al.. (2023). Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?. Annals of Surgical Oncology. 30(10). 6061–6069. 1 indexed citations
8.
Tadros, Audree B., Varadan Sevilimedu, Dilip D. Giri, et al.. (2021). Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype. Annals of Surgical Oncology. 28(8). 4245–4253. 32 indexed citations
9.
Tadros, Audree B. & George Plitas. (2021). ASO Author Reflections: Clinical Importance of Histologic Subtype for Metaplastic Breast Cancer. Annals of Surgical Oncology. 28(8). 4254–4255. 1 indexed citations
10.
Morrow, Monica, Kimberly J. Van Zee, Sujata Patil, et al.. (2017). Axillary Dissection and Nodal Irradiation Can Be Avoided for Most Node-positive Z0011-eligible Breast Cancers. Annals of Surgery. 266(3). 457–462. 81 indexed citations
11.
Plitas, George & Charlotte E. Ariyan. (2012). Controversies in the Management of Regional Nodes in Melanoma. Journal of the National Comprehensive Cancer Network. 10(3). 414–421. 4 indexed citations
12.
Bamboat, Zubin M., et al.. (2010). Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. Journal of Clinical Investigation. 120(2). 559–569. 152 indexed citations
13.
Brandl, Katharina, George Plitas, Coralia N. Mihu, et al.. (2008). Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature. 455(7214). 804–807. 508 indexed citations breakdown →
14.
Plitas, George, Bryan M. Burt, Hoang M. Nguyen, Zubin M. Bamboat, & Ronald P. DeMatteo. (2008). Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. The Journal of Experimental Medicine. 205(6). 1277–1283. 127 indexed citations
15.
Plitas, George, Bryan M. Burt, Jennifer Stableford, et al.. (2008). Dendritic cells are required for effective cross‐presentation in the murine liver†. Hepatology. 47(4). 1343–1351. 25 indexed citations
16.
Burt, Bryan M., George Plitas, Hoang M. Nguyen, et al.. (2008). Circulating HLA-DR+ natural killer cells have potent lytic ability and weak antigen-presenting cell function. Human Immunology. 69(8). 469–474. 22 indexed citations
17.
Brandl, Katharina, et al.. (2007). MyD88-mediated signals induce in vivo production of the bactericidal lectin RegIII{gamma} and protect against intestinal Listeria monocytogenes infection. The Journal of Immunology. 178. 23 indexed citations
18.
Chaudhry, Umer I., George Plitas, Bryan M. Burt, et al.. (2007). NK Dendritic Cells Expanded in IL-15 Exhibit Antitumor Responses In Vivo. The Journal of Immunology. 179(7). 4654–4660. 21 indexed citations
19.
Muhs, Bart E., Paul J. Gagne, George Plitas, Jason P. Shaw, & Peter Shamamian. (2004). Experimental hindlimb ischemia leads to neutrophil-mediated increases in gastrocnemius MMP-2 and -9 activity: a potential mechanism for ischemia induced MMP activation. Journal of Surgical Research. 117(2). 249–254. 30 indexed citations
20.
Plitas, George, Paul J. Gagne, Bart E. Muhs, et al.. (2003). Experimental Hindlimb Ischemia Increases Neutrophil-Mediated Matrix Metalloproteinase Activity: A Potential Mechanism for Lung Injury After Limb Ischemia. Journal of the American College of Surgeons. 196(5). 761–767. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026